Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: An analysis of the Nationwide Inpatient Sample

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Becerra, Monideepa B ^a,b,c   Becerra, Benjamin J ^b,d   Banta, Jim E ^d   Safdar, Nasia ^b,e  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c Loma Linda University ^*  (United States)

^d LOMA LINDA UNIVERSITY   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Clostridium difficile; Hospital acquired infection; Nationwide inpatient sample; Nosocomial infection; Pneumonia; Urinary tract infection

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PREVALENCE; RISK FACTOR; SEX RATIO; UNITED STATES; URBAN AREA; URINARY TRACT INFECTION; ADOLESCENT; CLOSTRIDIUM INFECTIONS; COINFECTION; COMMUNITY HOSPITAL; COMORBIDITY; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FACTUAL DATABASE; HOSPITAL PATIENT; MIDDLE AGED; ODDS RATIO; PEPTOCLOSTRIDIUM DIFFICILE; REGRESSION ANALYSIS; URINARY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COINFECTION; COMORBIDITY; CROSS INFECTION; DATABASES, FACTUAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, COMMUNITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; UNITED STATES; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84934274324     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0925-9     Document Type: Article

References (45)

1. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2011;32(4):387-90.
2. Lessa FC, Gould CV, McDonald LC. Current status of clostridium difficile infection epidemiology. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55 Suppl 2:S65-70.
3. Goudarzi M, Seyedjavadi SS, Goudarzi H, Mehdizadeh Aghdam E, Nazeri S. Clostridium difficile infection: epidemiology, pathogenesis, risk factors, and therapeutic options. Scientifica. 2014;2014, e916826.
4. Campbell RJ, Giljahn L, Machesky K, Cibulskas-White K, Lane LM, Porter K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2009;30(6):526-33.
5. Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, Allison MC. Proton pump inhibitor therapy is a risk factor for clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther. 2006;24(4):613-9.
6. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. Can Med Assoc J. 2004;171(1):33-8.
7. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243-5.
8. Norén T, Tang-Feldman YJ, Cohen SH, Silva J, Olcén P. Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis. 2002;42(2):149-51.
9. Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326-32.
10. Ricciardi R, Ogilvie JW, Roberts PL, Marcello PW, Concannon TW, Baxter NN. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum. 2009;52(1):40-5.
11. Nguyen GC, Kaplan GG, Harris ML, Brant SR. A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients. Am J Gastroenterol. 2008;103(6):1443-50.
12. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57(2):205-10.
13. Pant C, Deshpande A, Anderson MP, Sferra TJ. Clostridium difficile infection is associated with poor outcomes in end-stage renal disease. J Investig Med Off Publ Am Fed Clin Res. 2012;60(2):529-32.
14. Pant C, Anderson MP, O'Connor JA, Marshall CM, Deshpande A, Sferra TJ. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database. Transpl Infect Dis Off J Transplant Soc. 2012;14(5):540-7.
15. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis. 2007;13(9):1417-9.
16. Polgreen PM, Chen YY, Cavanaugh JE, Ward M, Coffman S, Hornick DB, et al. An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2007;28(2):212-4.
17. Agency for Healthcare Research and Quality. Introduction to the HCUP Nationwide Inpatient Sample (NIS) [Internet]. 2013. Available from: http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.pdf
18. Thompson DA, Makary MA, Dorman T, Pronovost PJ. Clinical and Economic Outcomes of Hospital Acquired Pneumonia in Intra-Abdominal Surgery Patients. Ann Surg. 2006;243(4):547-52.
19. Brinjikji W, Kallmes DF, Cloft HJ. Trends in epistaxis embolization in the United States: a study of the Nationwide Inpatient Sample 2003-2010. J Vasc Interv Radiol JVIR. 2013;24(7):969-73.
20. Kronman MP, Gerber JS, Prasad PA, Adler AL, Bass JA, Newland JG, et al. Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study. J Pediatr Infect Dis Soc. 2012;1(4):306-13.
21. Morton J, Anastassopoulos KP, Patel ST, Lerner JH, Ryan KJ, Goss TF, et al. Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. Am J Med Qual. 2010;25(4):289-96.
22. Banta JE, Joshi KP, Beeson L, Nguyen HB. Patient and hospital characteristics associated with inpatient severe sepsis mortality in California, 2005-2010. Crit Care Med. 2012;40(11):2960-6.
23. Becerra BJ, Becerra MB, Safdar N. A Nationwide Assessment of the Burden of Urinary Tract Infection among Renal Transplant Recipients. J Transplant. 2015;2015, e854640.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
25. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.
26. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-9.
27. US Department of Commerce, Bureau of Economic Analysis. Bureau of Economic Analysis [Internet]. 2014 [cited 2014 Jul 30]. Available from: http://www.bea.gov/iTable/iTable.cfm?reqid=9&step=3&isuri=1&904=2009&903=4&906=q&905=2014&910=x&911=0#reqid=9&step=3&isuri=1&904=2009&903=4&906=q&905=2014&910=x&911=0 .
28. Boone JH, Goodykoontz M, Rhodes SJ, Price K, Smith J, Gearhart KN, et al. Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2012;31(7):1551-9.
29. Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical Risk Factors for Severe Clostridium difficile-associated Disease. Emerg Infect Dis. 2009;15(3):415-22.
30. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007;142(7):624-31.
31. Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW. The changing prevalence of comorbidity across the Age spectrum. Crit Rev Oncol Hematol. 2008;67(2):124-32.
32. Soares M, Salluh JIF, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med. 2005;33(3):520-6.
33. Freitas A, Silva-Costa T, Lopes F, Garcia-Lema I, Teixeira-Pinto A, Brazdil P, et al. Factors influencing hospital high length of stay outliers. BMC Health Serv Res. 2012;12(1):265.
34. Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014;312(16):1677-84
35. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625-63.
36. Naber KG. Treatment options for acute uncomplicated cystitis in adults. J Antimicrob Chemother. 2000;46 Suppl 1:23-7. discussion 63-5.
37. Mehnert-Kay SA. Diagnosis and management of uncomplicated urinary tract infections. Am Fam Physician. 2005;72(3):451-6.
38. Lessa FC, Mu Y, Winston L, Dumyati G, Farley MM, Beldavs Z, et al. Determinants of Clostridium difficile Infection Incidence Across Diverse U.S. Geographic Locations. Open Forum Infect Dis. 2014;1(2) doi:10.1093/ofid/ofu048.
39. Mainous A, Hueston W, Clark J. Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold. J Fam Pract. 1996;42(4):357-61.
40. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278(11):901-4.
41. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA J Am Med Assoc. 2003;289(6):719-25.
42. Cohen SHMD, Gerding DNMD, Stuart Johnson M, Kelly CPMD, Loo VGMD, McDonald LCMD, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) •. Infect Control Hosp Epidemiol. 2010;31(5):431-55.
43. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478-98. quiz 499.
44. Scheurer DB, Hicks LS, Cook EF, Schnipper JL. Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect. 2007;135(6):1010-3.
45. Dubberke ER, Reske KA, McDonald LC, Fraser VJ. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis. 2006;12(10):1576-9.